Connect your AI

Celldex Therapeutics CLDX Net margin

Net margin at other companies

Eli LillyLLY

35%+12.3pp

PfizerPFE

15.7%—

Rogers CorporationROG

-7.4%-9.5pp

AmgenAMGN

21%+3.6pp

Regeneron PharmaceuticalsREGN

29.6%-2.3pp

IncyteINCY

26.7%+26.2pp

Other financials

Income statement

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

Operating margin-35,688.5%-39,114pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Calculated from Celldex Therapeutics’s reported figures.

net income/total revenue=-32,753.6%

Based on trailing twelve months.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Celldex Therapeutics's net margin?: Celldex Therapeutics (CLDX) reported net margin of -32,753.6% in Q1 2026.
How has Celldex Therapeutics's net margin changed year-over-year?: Celldex Therapeutics's net margin decreased by 1284.3% year-over-year, from -2,366.1% to -32,753.6%.
What is the long-term trend for Celldex Therapeutics's net margin?: Over 5 years (2020 to 2025), Celldex Therapeutics's net margin has grown at a 83.4% compound annual growth rate (CAGR), from -805.9% to -16,737.2%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.